Robert T Rosen

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Rutgers, The State University of New Jersey, Wellgen, Inc., Other. Active years: 1999-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert T Rosen. Retrieved from https://idiyas.com/inventor/robert-t-rosen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 97(Granted Patents)

Location History:

Pottersville, NJ (US) (1999)
Cranbury, NJ (US) (2003)
Monroe Township, NJ (US) (2002 - 2007)

Company Filing History:

8 out of 1,496

Rutgers, The State University of New Jersey

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2007

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7288680 - Benzotropolone derivatives and modulation of inflammatory response (2007-10-30),

2. 7238376 - Black tea extract for prevention of disease (2007-07-03),

3. 7201928 - Extracts of orange peel for prevention and treatment of cancer (2007-04-10),

4. 7087790 - Benzotropolone derivatives and modulation of inflammatory response (2006-08-08),

5. 6790869 - Resveratrol analogs for prevention of disease (2004-09-14),

6. 6627623 - Inducing cell apoptosis and treating cancer using 1-O-acetylbritannilactone or 1,6-O,O-diacetylbritannilactone (2003-09-30),

7. 6498195 - Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4′-hydroxyphenyl) as an anticarcinogenic agent (2002-12-24),

8. 5955269 - Methods of screening foods for nutraceuticals (1999-09-21),

9. 5859066 - Method for the treatment of itching (1999-01-12),

Title: The Innovations of Robert T. Rosen

Introduction

Robert T. Rosen is a notable inventor based in Monroe Township, NJ (US), recognized for his contributions to the field of medicinal chemistry. With a total of nine patents to his name, he has made significant strides in developing compounds that address inflammatory conditions and promote health benefits.

Latest Patents

Among his latest patents, Rosen has developed benzotropolone derivatives that are effective as antioxidant and anti-inflammatory agents. These compounds are represented by a general formula and include notable derivatives such as neotheaflavate B and EGCGCa. His innovative methods for synthesizing these benzotropolone compounds yield high quantities, providing a novel approach to treating inflammatory conditions. Additionally, he has patented compositions and methods utilizing black tea extract, which includes a mixture of theaflavin-3-gallate and theaflavin-3'-gallate, aimed at preventing and treating various diseases.

Career Highlights

Rosen has had a distinguished career, working at Rutgers, the State University of New Jersey, where he has contributed to research and development in his field. His work has not only advanced scientific understanding but has also led to practical applications in health and wellness.

Collaborations

Throughout his career, Rosen has collaborated with esteemed colleagues, including Geetha Ghai and Chi-Tang Ho, enhancing the impact of his research through shared expertise and innovation.

Conclusion

Robert T. Rosen's contributions to the field of medicinal chemistry through his patents and research have made a significant impact on health-related innovations. His work continues to inspire advancements in the treatment of inflammatory conditions and disease prevention.

Profile summary based on public USPTO records.